Source:http://linkedlifedata.com/resource/pubmed/id/15075332
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25
|
pubmed:dateCreated |
2004-6-14
|
pubmed:abstractText |
Previous studies indicated that treatment of cells with 12-O-tetradecanoylphorbol-13-acetate induced phosphorylation of Ser-985 at the juxtamembrane of c-Met, the receptor tyrosine kinase for hepatocyte growth factor (HGF), and this was associated with decreased tyrosine phosphorylation of c-Met. However, the regulatory mechanisms and the biological significance of the Ser-985 phosphorylation in c-Met remain unknown. When A549 human lung cancer cells were exposed to oxidative stress with H(2)O(2), H(2)O(2) treatment induced phosphorylation of Ser-985, but this was abrogated by an inhibitor for protein kinase C (PKC). Likewise, treatment of cells with NaF (an inhibitor of protein phosphatases) allowed for phosphorylation of Ser-985, and a protein phosphatase responsible for dephosphorylation of Ser-985 was identified to be protein phosphatase 2A (PP2A). The effects of PKC inhibitors revealed that PKCdelta and -epsilon were responsible for the Ser-985 phosphorylation of c-Met, and pull-down analysis indicated that associations of PKCdelta and -epsilon with c-Met may be involved in the regulation of Ser-985 phosphorylation of c-Met. Instead, PP2A was constitutively associated with c-Met, whereas its activity to dephosphorylate Ser-985 of c-Met was decreased when cells were exposed to H(2)O(2). Addition of HGF to A549 cells in culture induced c-Met tyrosine phosphorylation, the result being mitogenic response and cell scattering. In contrast, in the presence of H(2)O(2) stress, HGF-dependent tyrosine phosphorylation of c-Met was largely suppressed with a reciprocal relationship to Ser-985 phosphorylation, and this event was associated with abrogation of cellular responsiveness to HGF. These results indicate that Ser-985 phosphorylation of c-Met is bi-directionally regulated through PKC and PP2A, and the Ser-985 phosphorylation status may provide a unique mechanism that confers cellular responsiveness/unresponsivenss to HGF, depending on extracellular conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/Coloring Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoprotein Phosphatases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Phosphatase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met,
http://linkedlifedata.com/resource/pubmed/chemical/Serine,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Fluoride,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
279
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
26445-52
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15075332-Blotting, Western,
pubmed-meshheading:15075332-Bromodeoxyuridine,
pubmed-meshheading:15075332-Cell Line, Tumor,
pubmed-meshheading:15075332-Coloring Agents,
pubmed-meshheading:15075332-Enzyme Activation,
pubmed-meshheading:15075332-Enzyme Inhibitors,
pubmed-meshheading:15075332-Hepatocyte Growth Factor,
pubmed-meshheading:15075332-Humans,
pubmed-meshheading:15075332-Hydrogen Peroxide,
pubmed-meshheading:15075332-Models, Biological,
pubmed-meshheading:15075332-Oxidative Stress,
pubmed-meshheading:15075332-Phosphoprotein Phosphatases,
pubmed-meshheading:15075332-Phosphorylation,
pubmed-meshheading:15075332-Precipitin Tests,
pubmed-meshheading:15075332-Protein Binding,
pubmed-meshheading:15075332-Protein Isoforms,
pubmed-meshheading:15075332-Protein Kinase C,
pubmed-meshheading:15075332-Protein Phosphatase 2,
pubmed-meshheading:15075332-Proto-Oncogene Proteins c-met,
pubmed-meshheading:15075332-Serine,
pubmed-meshheading:15075332-Sodium Fluoride,
pubmed-meshheading:15075332-Time Factors,
pubmed-meshheading:15075332-Tyrosine
|
pubmed:year |
2004
|
pubmed:articleTitle |
Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor.
|
pubmed:affiliation |
Division of Molecular Regenerative Medicine, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|